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Summary 
Mechanisms of T  cell-mediated cytotoxicity remain poorly defined at the molecular level. To 
investigate some of these mechanisms, we used as target ceUs, on the one hand, thymocytes from 
lpr and g/d mouse mutants, and on the other hand, L1210 cells transfected or not with the apoptosis- 
inducing Fas molecule. These independent mutant or transfectant-based approaches both led to 
the  conclusion  that  Fas  was  involved in  the  CaZ+-independent component  of cytotoxicity 
mediated by at least two sources oft cells, namely nonantigen-spec'ific in vitro activated hybridoma 
cells, and antigen-specific in vivo raised peritoneal exudate lymphocytes. Thus, in these cases, 
T  ceU-mediated cytotoxicity involved transduction via Fas of the target cell death signal. 
p rogrammed ceU death, often called  apoptosis (1), mas- 
sively occurs within the immune system as a component 
of its normal development (2-4). Part of this process seems 
to involve the Fas cell surface molecule (5-8), which can trans- 
duce a ceU death signal (5,  6) and is not or is abnormally 
expressed (9) in the Ipr mutant mouse (for review, see refer- 
ence 10) exhibiting a lymphoproliferative  disorder. CeU death 
can also be imparted by the immune system, in particular 
through T cell-mediated cytotoxicity. Hypotheses as to the 
undefined and apparently multiple molecular mechanisms of 
this process range from direct membrane interactions to granule 
exocytosis (for review, see reference  11). We demonstrate in 
this report a role for Fas in some instances of both nonspecific 
and antigen-specific Ca2+-independent T  cell-mediated cy- 
totoxicity. Fas thus seems causally involved in cell death in 
both developmental and functional circumstances within the 
immune system. 
Materiah and Methods 
Culture Conditions, Cells, and Cytotoxicity Test.  All incubation 
and culture procedures were at 37~  in a water-saturated 5% CO2 
atmosphere. Cells (except PC60 and its derived  clones) were grown 
in RPMI 1640 medium (Gibco Bio-Cult, Glasgow, Scotland) en- 
riched with 10% FCS (Biological Industries, Beth Halmeck, Is- 
rael) and supplemented with 2  x  10  s M 2-ME, penicillin, and 
streptomycin. PC60 is a bybridoma (12) between a mouse cyto- 
toxic T cell done with antimale D b specificity (13) and a deriva- 
tive from the rat T lymphoma W/Fu (C58NT)D. PC60 cells and 
all PC60-derived cells were grown and cloned in DMEM (Gibco 
Biocult, Uxbridge, UK) enriched with 5% FCS and the additives 
above. Cytotoxicity tests were carried out in V-shaped wells of 
96-well microtiter plates with SlCr-labeled target cells (104 tumor 
cells or 10  s thymocytes) and effector cells (PC60-derived dl0S cells 
or peritoneal exudate cells [14]) at the indicated ratios in a total 
volume per well of 200/A of ILPMI medium with 10% FCS. The 
plates were centrifuged (200 g, 2 rain) and incubated for 4 h at 
37~  After another centrifugation, 100-#1 aliquots of supemates 
were assayed  for radioactivity.  The fraction of  the total radioactivity 
released was then calculated, and the results were expressed as per- 
cent experimental SICr-release -  percent SlCr-release from target 
cells alone, dl0S cells were incubated before and/or during the cy- 
totoxicity tests with a mixture of PMA (Sigma Chemical Co., St. 
Louis, MO; final  concentration 5 ng/ml) and the Ca  2+ ionophore 
ionomycin (Calbiochem Corp., San Diego, CA; final concentra- 
tion 3 gg/ml). 
Mice.  4-6-wk-old  MRL/Mp/Ola/Hsd  and  MRL/Mp- 
Ipr/Ola/Hsd mice were obtained from Harlan Olac (Oxon, UK). 
C57BI/6J-I  W or C57B1/6J-g/d  mice were obtained  from The Jackson 
Laboratory (Bar Harbor, ME). Other mice were bred at the Centre 
d'Immunologie. 
Fas and Fas Transfectants.  A cDNA spanning the entire coding 
region of  the murine Fas antigen was obtained by reverse transcrip- 
tion (RT)-PCR using oligonudeotides corresponding to nucleo- 
tides 39-58 and 1294-1313 of the published sequence (8), flanked 
by EcolLI restriction sites to facilitate further cloning. 1 #g of 
poly(A)  +  B6  thymus  mRNA  was  reverse transcribed  using 
random hexamers (Pharmacia, Uppsala, Sweden) and Superscript 
mouse murine leukemia virus-H-  reverse transcriptase (Bethesda 
Research Laboratories  [BILL],  Gaithersburg, MD) for 1 h at 37~ 
The reaction was incubated at 90~  for 5 min and 2 U of RNase 
H (BILL)  were added. The reaction was further incubated for 20 
rain at 37~  For PCR, 3/~1 of the cDNA reaction was used with 
50 pmol of  phosphoryhted oligonucleotide  primers. The cycles  were: 
5 min at 94~  followed by 6 cycles (1 min, 94~  2 min, 55~ 
and 3 rain, 72~  and 26 cycles (1 min, 94~  2 rain, 60~  and 
3 rain, 72~  followed by 15 min at 72~  2.5 U of PFU poly- 
merase (Strategene  Inc., La  Jolla, CA) was added after the annealing 
step of the first cycle. The PCR products were electrophoresed in 
Tris-acetate/EDTA buffer, an expected  band of about 1,300 bp was 
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EcolLl (Boehringer, Mannheim,  Germany) for 1 h at 37~  fol- 
lowed by 10 min at 65~  to inactivate the enzyme. This DNA 
was ligated with EcogI-cut, calf intestine  alkaline phosphatase- 
treated pBhescript II KS (-) vector (Stratagene Inc.) overnight 
at 15~  The ligation mixture was then dialysed and electropo- 
rated into XL1 Bhe bacteria (Stratagene Inc.). White colonies ob- 
tained after blue/white selection with XGal and isopropylthio-fl- 
D-galactoside were analyzed for the presence of a 1,300-bp insert 
by PCK using T3 and T7 primers. Five "positive" clones were ob- 
tained, of which two were partially sequenced  using a T7 sequencing 
kit (Pharmacia Fine Chemicals, Piscataway, NJ). Both clones were 
shown to contain both ends of the expected Fas sequence. Both 
inserts were digested out of the pBluescript II KS(-) vector with 
EcoRI, purified by electrophoresis and dectroelution, cloned in 
the EcoRI site of a modified pHflAPrl-neo vector, and introduced 
in XL1 Blue. Two clones with the Fas cDNA correctly oriented 
towards the fl-actin promoter were fully sequenced using internal 
primers. One of these clones, called pHflAPrl-neo-Fas 49, was iden- 
tical to the published Fas sequence (8). Its DNA was prepared, 
purified by two CsC1 gradients, and used to dectrotransfect  L1210 
calls. After electroporation,  the cells were seeded at 5  x  104-10  s 
cells per well in 24-well microtiter  plates and selected with G418 
(1-1.5 mg/ml) (BRL). One of the resistant clones (called here L1210- 
Fas) was further tested for expression of Fas by Northern blots and 
for sensitivity to dl0S incubated with PMA plus ionomycin (PI). 
Another round of transfection  (data not shown) provided other 
L1210-Fas transfectants, some of which were also sensitive to dl0S 
PI,  whereas control vector-transfected L1210 cells were not. 
Northern Blots.  A volume of 10 #g of total RNA was electro- 
phoresed per lane and blotted on nitrocellulose (Hybond N; Amer- 
sham Corp., Arlington Heights, IL). The membrane was prehybri- 
dized for 4 h at 42~  and hybridized with a Fas probe (6  x  105 
cpm/ml) overnight at 42~  The blot was washed twice at 65~ 
in  2x  SSC-0.1%  SDS and  autoradiographed  on  Hyperfilm  TM 
(Amersham Corp.). 
Results and Discussion 
Fas Involvement  in a Model  T  Cell-mediated  Cytotoxicity 
System.  A convenient initial model was provided by the rat 
x  mouse hybridoma PC60 obtained by Conzelmann  et al. 
(12),  which we serially cloned with systematic selection of 
the most cytotoxic clones (data not shown). The experiments 
described below used cells from the 10th serial subcloning, 
called PC60-dl0S (dl0S). Very similar results were obtained 
with later subdones.  Whereas mixtures of interleukins  in- 
duced the cytotoxic activity of PC60 in a matter of days (15), 
PI induced cytotoxicity much more readily. Effector dl0S cells 
preincubated with PI for 3 h (dl0S PI) or even subjected to 
PI only for the duration of the 4-h cytotoxicity test lysed, 
more efficiently than if untreated,  YAC target cells (Fig.  1 
a) and also thymocytes at particularly low E/T  cell ratios 
(Fig. 1 b). Other characteristics (data not shown) of this cy- 
totoxicity  system were:  (a)  lysis  was not  MHC restricted 
(thymocytes of various MHC haplotypes, and the MHC-low 
YAC.5.2 cells [16] could be lysed) and could be inhibited in 
part by an anti-LFA-1 mAb antibody; (b) supernatants from 
dl0S cells activated with PI were not lytic, even when highly 
concentrated,  and  even when  collected from  mixtures  of 
effector and target cells; (c) cytolysis was not altered by addi- 
tion of hexokinase or ATPase,  N~ 
acetate (thus implying no involvement of nitric oxide),  an 
anti-TNF-o~  antiserum,  or the lectin Con A; and (d) target 
cell death was accompanied by an apoptotic-type pattern of 
DNA  fragmentation  (17-19)  and  did  not  require  macro- 
molecular  synthesis. 
We considered the observation that thymocytes were sen- 
sitive to this type of cytotoxicity (Fig.  1 b) in the light of 
recent results showing that Fas is expressed on mouse thymo- 
cytes (8). To investigate whether Fas at the surface of target 
thymocytes might be causally involved in their lysis by dl0S 
effector cells, we used thymocytes from lpr mutant mice, which 
do not express Fas (9). Whereas MILL thymocytes were sen- 
sitive (Fig.  1 c), MRL-Ipr thymocytes were resistant (Fig.  1 
d)  to dl0S cells,  even in the presence of Con A  (data not 
shown). The absence of lysis of Ipr thymocytes by dl0S cells 
was observed not only on the MRL, but also on the C57B1/6 
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Figure I.  Cytotoxic activity of dl0S cells. "I~rget cells were 
tither  YAC  cells  (a)  or  tbymocytes  from  C57B1/6  (b), 
MRL/Mp/Oh/Hsd (c) and MR.L/Mp-lFr/Ola/Hsd  (4 mice. 
dl0S cells (from the 10th serial subcloning of ~)  were 
induced  to  cytoto~dchy  by  incubation  with  PMA  and 
ionomycin, either for 3 h at 37~  before the cytoto~dchy test 
(4  ￿  105 cells/10 ml of medium in a 75-ml tissue culture 
flask; pretest, m), or by directly adding the mixture of PMA 
and ionomycin to the cytotoxicity test (in test, Q). In other 
groups both (O) or neither (D) induction procedures were 
followed. The results were  expressed  as percent experimental 
slCr-release minus percent slCr-release from target cells 
alone. In this experiment, the latter was 15-21%. 50. 
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Figure  2.  Differential  sensitivity 
of thymocytes  from wild type or 
mutant C57B1/6 mice to dlOS or 
PEbmediated cytotoxicity. Target 
cells were  thymocytes  from  6--8-wb 
old mice, either  C57B1/6 (a and d), 
or  C57B1/6J-Ipr (b  and  e)  or 
C57B1/6J-g/d  (c  and f).  (a-c) 
Effector cells were either d10S PI 
(Q), or b anti-k (between spleen 
cells from C3H, k, and C57B1/6, 
b) 5-d MLC cells plus Con A (10 
/~g/ml final)  in the cytotoxicity  test 
(ram); the latter calls were  not cyto- 
toxic to these  thymocytes  in the ab- 
sence of Con A. In a separate ex- 
periment (d-f), effector  cells were 
BALB/c  anti-EL4  primary  PEL sam- 
pied on day 11 and purified  by two 
passages through nylon wool col- 
umns (final call recovery 15%). 
The cytotoxicity  test was performed 
either in complete  medium  (F']) or 
in  the presence of EGTA-Mg  2+ 
(am). Spontaneous  slCr-release  was 
21-38%. 
(Fig. 2 b) mouse backgrounds. Thus, thymocytes from mice 
not expressing Fas were resistant to dl0S cells. In contrast, 
thymocytes f~om g/d mice (20), which express Fas while having 
the same cellular phenotype as Ipr mice (10) presumably due 
to the lack of the Fas ligand (21), were sensitive to dlOS (Fig. 
2 c). This indicated that Ipr resistance was directly related 
to the absence of Fas at the target MR.blpr thymocyte sur- 
face, not to a  secondary consequence of this mutation on 
thymocyte development. In the presence of Con A, C57B1/ 
6-1pr thymocytes remained resistant to dl0S (data not shown), 
but were nonspecifically lysed by MLC cells (Fig. 2 b), which 
provided a dearly Fas-unrelated positive lysis control. In line 
with the involvement in dl0S-mediated lysis of the cell surface- 
expressed Fas molecule, the lysis by dl0S calls of YAC calls 
and of MRL thymocytes was inhibited by MILL more than 
by MRblpr thymocytes, and also, in an MHC allde-unrelated 
manner, by C57B1/6 more than by C57B1/6 Ipr thymocytes 
(data not shown). 
To provide another, independent demonstration of the role 
of Fas as a target cell molecule transducing a cell death signal 
in some cytotoxicity systems, we converted an insensitive call 
into a sensitive one by transfection with Fas. Although most 
of the 15 cell lines we tested, including YAC, EL4, and P815 
(Fig. 3, a-c), were lysed by dl0S PI, the L1210 lymphocytic 
mouse leukemic cell line was found insensitive to dl0S PI 
(Fig. 3 d). Consistent with a requirement for Fas in the lysis 
by dl0SPI, Fas transcripts were undetectable or abnormal in 
insensitive L1210 cells and Ipr thymocytes, and were present 
in sensitive YAC cells and wild type thymocytes (Fig.  3 ~. 
Transfection of Fas into L1210 conferred to these cells weak 
but definite Fas mRNA expression on the one hand (Fig. 
3.f), and sensitivity to dl0S PI on the other (Fig. 3 e). This 
line of evidence for the role of Fas in dl0S PI-mediated cyto- 
toxicity was independent from the one described above in 
that it involved L1210 cells rather than thymocytes, transfec- 
rants rather than mutants, and gain rather than loss of senti- 
tivity. From another point of view, cytotoxidty was similar 
in  the absence or presence of EGTA-Mg  ~§  (Fig.  3, a-e), 
showing the Ca  z+ independence of d10S PI-mediated Fas- 
transduced cytotoxicity. 
Fas Involvement in Ca2+-independent Antigen-specific T Cell- 
mediated Cytotoxicit,/  The involvement of  Fas was not limited 
to dl0S PI-mediated cytotoxicity. It was also found for other 
antigen nonspecific PI-induced T cells (data not shown). To 
investigate antigen-specific cytotoxicity, we used peritoneal 
exudate lymphocytes (PEL), a model developed by Berke et 
al. (14) of potent spedfic in vivo-raised cytotoxic T cells. In 
view of the results with dl0S PI, we especially considered 
the known Ca2+-independent components (22, 23) of PEL- 
mediated cytotoxicity. 
When tested on thymocytes, PEL showed (Fig.  2 d) two 
components  of lysis,  requiring  or  not  requiring  CF +, 
respectively. Both of these components were antigen specific, 
since they lysed only (data not shown) the antigenically rele- 
vant thymocytes, in line with previous observations that the 
Ca2+-independent components of MLC or PEbmediated cy- 
totoxicity were indeed antigen specific (22).  However, the 
Ca2+-dependent component lysed, and the Ca2+-indepen  - 
dent  component did  not  lyse,  Ipr thymocytes (Fig.  2  e). 
Moreover, B6 gld thymocytes behaved like wild type, not Ipr, 
thymocytes (Fig. 2f), strongly indicating that the observed 
insensitivity of Ipr thymocytes to  Ca2§  PEL- 
mediated cytotoxicity was directly related to the absence of 
Fas at their surface.  As an independent further demonstra- 
tion, when tested on tumor target cells, the Ca~+-indepen  - 
dent component of H-2d-specific PEDmediated lysis (Fig. 4) 
spared L1210 (as observed before [23]) and YAC, and affected 
P815 and L1210-Fas. Thus, the two former cells, which lacked 
197  gouvier r  aI.  Brief  Definitive Report Figure 3.  Sensitivity to dl0S PI-mediated cytotoxicity of, and Fas ex- 
pression in, YAC, EL4, P815, L1210, and L1210-Fas, i.e., L1210 transfected 
with Fas cDNA. The cytotoxicity test (a--e)  was performed either in con- 
ventional medium (I-1) or in the presence of EGTA-Mg  2+ (I). Sponta- 
neous slCr-release was 6-17%. A Northern blot of R.NA from the indi- 
cated cells ~  was hybridized with a Fas probe. (Arrow) Migration of the 
main Fas transcript. 
Fas (Fig. 3, d and.f) or a recognized alloantigen (Fig. 4 d), 
respectively, were not lysed. The two latter, which bore both, 
could be lysed. All these results pointed to the requirement 
for antigen-specific  Ca2+-independent T  ceU-mediated cy- 
totoxicity of  both specific allorecognition and presence of Fas 
at the target cell surface. 
This report provides modds for cell-mediated cytotoxicity 
mechanisms involving molecular interactions between a ligand 
at the effector cell surface, and a receptor at the target cell 
surface (here, Fas) transducing a cell death signal.  Another 
example may be macrophage or lymphocyte  membrane-bound 
TNF (24-28) and TNF receptors,  the latter being structur- 
ally  related  to  Fas  (7).  Such mechanisms, making use of 
membrane-bound  molecules related or not to those discussed 
here, would account for characteristics of cell-mediated cyto- 
toxicity such as the polarity of lysis sparing the effector cells 
(29)  and the apoptosis mode of target cell death (18, 19). 
dl0S-mediated cytotoxicity requires the Fas molecule at the 
target cell surface, which signals an apoptotic cell death ma- 
chinery within the target cell. This suggests that the killing 
machinery of the PI-induced dl0S effector cell comprises a 
cell surface-expressed Fas ligand. Of practical interest, these 
cells may thus represent a good source material for the mo- 
lecular doning of this ligand. Alternatively, the effector cell 
ligand may recognize on the target cell surface not Fas but 
a molecule functionally associated with Fas. In any case, the 
same Fas molecule seems causally involved within the im- 
mune system in some types of ceU-mediated cytotoxicity and 
in developmental ceU death. 
Antigen-specific Ca2+-independent  cytotoxicity would re- 
quire in addition expression of the relevant TCR on effector 
cells and the relevant MHC on target cells. Thus, in this type 
of cytotoxicity, at the effector ceU surface both the TCK and 
a Fas ligand would engage the corresponding target cell sur- 
face molecules, leading to antigen-spedfic, Fas-transduced 
target ceU death. Hypothetically, at the surface of some cyto- 
toxic T cells, the functional availability of a Fas ligand may 
be induced by antigen-specific  engagement of the TCR, or 
by antigen nonspedfic signals such as interleukins or phorbol 
ester and calcium ionophore. This would lead to antigen- 
specific or nonspecific lysis, respectively, of Fas-bearing target 
ceils. 
In vivo, Fas-based cytotoxicity pathways must be limited 
by expression of both a functional Fas ligand among effector 
cells and Fas among putative target ceils. Fas expression has 
been reported, in mouse (8), in thymus, liver, ovary, and heart, 
but could not be detected in brain,  spleen, bone marrow, 
kidney, testis,  and uterus. In man (5-7, 30-32), Fas (iden- 
tical to APO-1 [33]) was found expressed on various cell types 
such as myeloid cells and fibroblasts,  on some but not all B 
and T lymphoid cell lines, on activated more than on resting 
80. 
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Figure 4.  Differential sensitivity 
of tumor and transfectant cells to 
Ca2 +-independent antigen-sl~-ific 
PEI,mediated cytotoxidty. Effector 
cells were CBA anti-P815 primary 
PEL sampled on day 11 and purified 
by one passage through  a  nylon 
wool  column (final cell recovery 
27%).  The cytntoxicity  test  was 
performed  either  in  complete 
medium ([~) or in the presence of 
EGTA-Mg~+ (11). Incubation in 
the presence of Con A provided a 
positive ly~is  control on YAC target 
ceils (do~d line). Spontaneous slCr- 
release was 8-16%. 
198  Fas and T  Cell-mediated Cytotoxicity lymphocytes, and on some virus-infected lymphocytes. It is 
interesting that the expression of Fas could be induced by 
IFN--r  (7,  8). 
The involvement of Fas shown here acco,,nts for only part 
(about 10-20% according to Figs. 2 and ,t, consistent with 
previous estimates [22]) of specific T cell-mediated cytotox- 
icity, namely its CaZ+-independent component.  Fas-based 
mechanisms may weU account for most of this component, 
at least with the target cells used here,  since absence of Fas 
led to undetectable CaZ+-independent cytotoxicity. In con- 
trash the Ca2+-dependent  mechanisms of cytotoxicity tested 
here did not require Fas. They may use other membrane mol- 
ecules or altogether different lysis mechanisms involving for 
example,  exocytosis. 
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